{"id":101312,"date":"2024-05-21T11:42:24","date_gmt":"2024-05-21T09:42:24","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?post_type=ecosystem&#038;p=101312"},"modified":"2024-05-21T11:45:30","modified_gmt":"2024-05-21T09:45:30","slug":"2na-fish","status":"publish","type":"ecosystem","link":"https:\/\/cms.munich-startup.net\/en\/startups\/2na-fish\/","title":{"rendered":"2NA FISH"},"content":{"rendered":"<div class=\"entry-content\"><p>Heterogeneous tumors contain a few cancer cells (5-15%) and a multitude of other cells, such as immune cells and fibroblasts. They are difficult to treat because current diagnostic methods put all these cell types into a &quot;blender&quot; and then attempt to measure biomarkers in the resulting &quot;smoothie.&quot;<\/p>\n<p>2NA FISH aims to revolutionize cancer treatment decisions by developing the first spatial transcriptomics technology for clinical cancer diagnostics. By measuring up to 50 RNAs in a single-cell spatial context, we can provide more precise and predictive diagnostics for cancer treatment decisions.<\/p>\n<\/div>","protected":false},"featured_media":101313,"comment_status":"closed","ping_status":"closed","template":"","tags":[],"ecosystem_type":[],"ecosystem_tag":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>2NA FISH - Munich Startup<\/title>\n<meta name=\"description\" content=\"Das M\u00fcnchner Startup 2NA Fish entwickelt eine Plattformtechnologie f\u00fcr therapieentscheidende In-Vitro-Diagnostika f\u00fcr Krebserkrankungen.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/startups\/2na-fish\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2NA FISH - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Das M\u00fcnchner Startup 2NA Fish entwickelt eine Plattformtechnologie f\u00fcr therapieentscheidende In-Vitro-Diagnostika f\u00fcr Krebserkrankungen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/startups\/2na-fish\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-21T09:45:30+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/startups\/2na-fish\/\",\"url\":\"https:\/\/cms.munich-startup.net\/startups\/2na-fish\/\",\"name\":\"2NA FISH - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/startups\/2na-fish\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/startups\/2na-fish\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/05\/2NA-FISH.jpeg\",\"datePublished\":\"2024-05-21T09:42:24+00:00\",\"dateModified\":\"2024-05-21T09:45:30+00:00\",\"description\":\"Das M\u00fcnchner Startup 2NA Fish entwickelt eine Plattformtechnologie f\u00fcr therapieentscheidende In-Vitro-Diagnostika f\u00fcr Krebserkrankungen.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/startups\/2na-fish\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/startups\/2na-fish\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/startups\/2na-fish\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/05\/2NA-FISH.jpeg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/05\/2NA-FISH.jpeg\",\"width\":768,\"height\":512,\"caption\":\"2NA FISH\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/startups\/2na-fish\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"2NA FISH\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2024\/05\/2NA-FISH.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"768\" \/>\n\t<meta property=\"og:image:height\" content=\"512\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"2NA FISH - Munich Startup","description":"The Munich-based startup 2NA Fish is developing a platform technology for therapy-critical in-vitro diagnostics for cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/startups\/2na-fish\/","og_locale":"en_US","og_type":"article","og_title":"2NA FISH - Munich Startup","og_description":"Das M\u00fcnchner Startup 2NA Fish entwickelt eine Plattformtechnologie f\u00fcr therapieentscheidende In-Vitro-Diagnostika f\u00fcr Krebserkrankungen.","og_url":"https:\/\/cms.munich-startup.net\/en\/startups\/2na-fish\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_modified_time":"2024-05-21T09:45:30+00:00","twitter_card":"summary_large_image","twitter_site":"@munich_startup","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/startups\/2na-fish\/","url":"https:\/\/cms.munich-startup.net\/startups\/2na-fish\/","name":"2NA FISH - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/startups\/2na-fish\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/startups\/2na-fish\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/05\/2NA-FISH.jpeg","datePublished":"2024-05-21T09:42:24+00:00","dateModified":"2024-05-21T09:45:30+00:00","description":"The Munich-based startup 2NA Fish is developing a platform technology for therapy-critical in-vitro diagnostics for cancer.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/startups\/2na-fish\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/startups\/2na-fish\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/startups\/2na-fish\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/05\/2NA-FISH.jpeg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/05\/2NA-FISH.jpeg","width":768,"height":512,"caption":"2NA FISH"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/startups\/2na-fish\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"2NA FISH"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]},"og_image":[{"width":768,"height":512,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/05\/2NA-FISH.jpeg","type":"image\/jpeg"}]},"_location_name":"","_location_street":"Ernst-Otto-Fischer-Str. 8","_location_zip":"85748","_location_city":"Garching","_ecosystem_type":"startup","_foundingyear":"2021","_showyear":"1","_show_financing":"","_inactive":"","_founders":"2","_employees":"6","_businessmodel":"B2B","_stage":"Seed-Stage","_financing":"","_investors":"","_investor_funding_rounds":"","_investor_details":"","_financing_history":"[{\"ecosystem_funding_round\":\"\",\"ecosystem_funding_year\":\"\",\"ecosystem_funding_amount\":\"\"}]","_apple_appstore":"","_google_play":"","_user_email":"johannes.breulmann@2nafish.bio","_user_password":"$2y$10$UQ3k0juEPH\/C2ZX0CxAFBuOg89HoVqSu3ewGmAEpjzfexLyXhciR6","_description_en":"Heterogeneous tumours contain few cancer cells (5-15%) and a variety of other cells, e.g. immune cells and fibroblasts. They are hard to treat because current diagnostics put all of those cell types in a blender and then try to measure biomarkers in the resulting \u201csmoothie\u201d. 2NA FISH aims to revolutionize therapy decisions in cancer by building the first spatial transcriptomics technology for clinical cancer diagnostics. Through single-cell measurement of up to 50 RNAs in the spatial context we can build more precise and predictive diagnostics for therapy decisions in cancer.","_founders_description":"","_founders_image":"","_logo_image":"","_contact":{"tel":"","hp":"https:\/\/2nafish.bio","mail":"johannes.breulmann@2nafish.bio","facebook":"","twitter":"","instagram":"","linkedin":"https:\/\/www.linkedin.com\/company\/2nafish\/"},"_thumbnail_id":"101313","_edit_lock":"1736512134:25","_edit_last":"25","_location_lat":"48.26971810000001","_location_long":"11.672456","_wp_old_slug":"","wbounce_status":"default","_yoast_wpseo_primary_ecosystem_type":"2","_yoast_wpseo_primary_ecosystem_tag":"2707","_hide_on_map":"","_yoast_wpseo_content_score":"60","dealroom_id":"5381323","_dealroom_id":"field_5ea15c1318719","dealroom_json":"{\"id\":5381323,\"name\":\"2NA FISH\",\"url\":\"https:\/\/app.dealroom.co\/companies\/2na_fish\",\"total_funding\":0,\"employees_chart\":[{\"date\":\"2024-05-21\",\"value\":9},{\"date\":\"2024-06-05\",\"value\":10}],\"employees_latest\":10,\"employee_12_months_growth_unique\":null,\"employee_12_months_growth_percentile\":null,\"app_12_months_growth_percentile\":null,\"app_12_months_growth_unique\":null,\"app_12_months_growth_relative\":null,\"fundings\":{\"items\":[],\"total\":0}}","_dealroom_json":"field_5ea15c251871a","dealroom_analytics_json":"{\"twitter_followers_chart\":[],\"facebook_likes_chart\":[]}","_dealroom_analytics_json":"field_5ea8354f2b0eb","_yoast_wpseo_focuskw":"2NA FISH","_yoast_wpseo_metadesc":"Das M\u00fcnchner Startup 2NA Fish entwickelt eine Plattformtechnologie f\u00fcr therapieentscheidende In-Vitro-Diagnostika f\u00fcr Krebserkrankungen.","_yoast_wpseo_linkdex":"43","_yoast_wpseo_estimated-reading-time-minutes":"1","_wp_old_date":"","_wp_desired_post_slug":"","_year":"","_yoast_wpseo_wordproof_timestamp":"","_yoast_wpseo_focuskw_text_input":"","_original_post_id":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/ecosystem\/101312"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/ecosystem"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/ecosystem"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=101312"}],"version-history":[{"count":0,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/ecosystem\/101312\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/101313"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=101312"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=101312"},{"taxonomy":"ecosystem_type","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/ecosystem_type?post=101312"},{"taxonomy":"ecosystem_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/ecosystem_tag?post=101312"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}